80% Oxygen: After successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 80%, and the total gas flow rate will be set at 2L/minute.
40% Oxygen: After successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 40%, and the total gas flow rate will be set at 2L/minute.
This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery.
| Facility | City | Region | Status |
|---|---|---|---|
| the First Hospital of China Medical University | Shenyang | Liaoning | Recruiting |
| Beijing Friendship Hospital, Capital Medical University | Beijing | China | Recruiting |
| Sichuan Provincial People's Hospital | Chendu | China | Recruiting |
| Chifeng Municipal Hospital | Chifeng | China | Recruiting |
| Dalian Third People's Hospital | Dalian | China | Recruiting |
| First Affiliated Hospital, Dalian Medical University | Dalian | China | Recruiting |
| First Affiliated Hospital of Harbin Medical University | Harbin | China | Recruiting |
| Harbin Medical University Cancer Hospital | Harbin | China | Recruiting |
| First Medical University and Shandong Provincial Qianfoshan Hospital | Jinan | China | Recruiting |
| First Affiliated Hospital of Kunming Medical University | Kunming | China | Recruiting |
| Affiliated Hospital of Qingdao University | Qingdao | China | Recruiting |
| Liaoning Cancer Hospital and Institute | Shenyang | China | Recruiting |
| Shenzhen People's Hospita | Shenzhen | China | Recruiting |
| First Hospital of Hebei Medical University | Shijia Zhuang | China | Recruiting |
| Second Hospital of Hebei Medical University | Shijia Zhuang | China | Recruiting |
| YANBIAN University Hospital(Yanbian Hospital) | Yanbian | China | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06359106 on ClinicalTrials.gov ↗ ← All trials in China